Researchers from the National University of Singapore (NUS) have demonstrated an innovative approach for targeted breast ...
Gliomas are a major cause of cancer-related deaths in younger adults. About 7,000 patients harbor a common genetic mutation ...
In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...
SAN CARLOS, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the ...
Researchers from the National University of Singapore (NUS) have demonstrated an innovative approach for targeted breast cancer therapy using pulsed electromagnetic fields (PEMFs). The NUS team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results